Long intergenic non-protein coding RNA 2205 (LINC02205)

Long intergenic non-protein coding RNA 2205 (LINC02205) is a long intergenic non-coding RNA (lincRNA) gene that does not overlap protein-coding sequences and is transcribed into a non-coding RNA molecule longer than 200 nucleotides[1][3][7]. These lincRNAs generally function as regulators of gene expression through various mechanisms, such as remodeling chromatin, modulating RNA stability, or interacting with transcriptional machinery[3][5][7]. LINC02205 itself has not been characterized as a disease-associated molecule, biomarker, or drug target in the literature, though other lincRNAs do participate in regulatory and disease processes, sometimes making them potential molecular therapeutic targets[2][3][5].\n\nMost lincRNAs, including LINC02205, are not considered classical "drug targets" but may influence cellular pathways and disease phenotypes, and their role as potential targets in future molecular medicine could evolve as research advances[3][5].\n\nIf you meant LINC00205 (a similar-sounding but distinct molecule), this lincRNA does play a role as a **potential oncogene** in gastric cancer progression, regulates cell proliferation, migration and invasion, and has been suggested as a therapeutic target or biomarker in cancer research[2]. There is frequent confusion in literature between different lincRNA names, emphasize "LINC02205" if seeking information on this specific gene[2].

Other names

LINC02205